** Shares of biotech firm Evaxion Biotech EVAX.O fall 28.6% to $2.42
** EVAX says it is raising $10.8 mln through public offering
** EVAX is selling ~4 mln of its American Depositary Shares at $2.71/shr, along with warrants to buy additional shares
** Offering priced at 20% discount to stock's last close
** Funds will be used to advance EVAX's vaccine development pipeline and cover operating expenses, co says
** EVAX has ~1.2 mln outstanding shares, with market cap of ~4 mln - LSEG data
** Lake Street Capital Markets and Jones are acting as exclusive placement agents for offering
** EVAX fell ~91% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。